首页>
外国专利>
Pharmaceutical compositions, useful e.g. for the treatment of neurodegenerative diseases, psychiatric or neuropathological diseases or especially pain and epilepsy, comprise N,N'-disubstituted piperazine derivatives
Pharmaceutical compositions, useful e.g. for the treatment of neurodegenerative diseases, psychiatric or neuropathological diseases or especially pain and epilepsy, comprise N,N'-disubstituted piperazine derivatives
Pharmaceutical compositions comprising N,N'-disubstituted piperazine derivatives (I) are new. Pharmaceutical compositions comprising N,N'-disubstituted piperazine derivatives of formula (I), in the form of diastereomers, enantiomers or their mixtures (including racemates) and free bases, salts or solvates, optionally together with auxiliaries, are new. R1, R2 = linear or branched, saturated or unsaturated aliphatic residue; R1+R2 = (CH2)n; n = integer; R3, R5 = linear or branched, saturated or unsaturated aliphatic residue, saturated or unsaturated cycloaliphatic residue, aryl or heteroaryl (the ring systems are optionally substituted and optionally bonded via a linear or branched, saturated or unsaturated aliphatic bridge, the aryl or heteroaryl residues optionally being part of a polycyclic system); and R4 = H; or aryl or heteroaryl (both optionally substituted and optionally forming part of a polycyclic system).
展开▼
机译:包含N,N′-二取代哌嗪衍生物(I)的药物组合物是新的。以非对映异构体,对映异构体或它们的混合物(包括外消旋体)和游离碱,盐或溶剂化物的形式包含非必需的N,N′-二取代的哌嗪衍生物的药物组合物是新的,所述的碱,盐或溶剂化物是任选的。 R 1,R 2 =直链或支链的饱和或不饱和脂族残基; R 1 + R 2 =(CH 2)n; n =整数; R 3,R 5 =直链或支链的饱和或不饱和脂族残基,饱和或不饱和的脂环族残基,芳基或杂芳基(环系统任选地被取代并且任选地通过直链或支链的饱和或不饱和脂族桥键合) ,芳基或杂芳基残基任选地是多环系统的一部分);并且R 4 = H;或芳基或杂芳基(两者均任选地被取代并且任选地形成多环系统的一部分)。
展开▼